Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil
- 1 June 2000
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 13 (S1), S301-S305
- https://doi.org/10.1111/j.1432-2277.2000.tb02045.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Mycophenolic acid monitoring: evaluation of the EMIT MPA immunoassay in kidney and lung transplantationTransplantation Proceedings, 1999
- Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional studyNephrology Dialysis Transplantation, 1999
- Drug monitoring of mycophenolic acid in the early period after renal transplantationTransplantation Proceedings, 1998
- Therapeutic monitoring of mycophenolic acid: A consensus panel reportClinical Biochemistry, 1998
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- PHARMACODYNAMIC ASSESSMENT OF MYCOPHENOLIC ACIDINDUCED IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1996
- PHARMACODYNAMIC ASSESSMENT OF MYCOPHENOLIC ACID-INDUCED IMMUNOSUPPRESSION BY MEASUREMENT OF INOSINE MONOPHOSPHATE DEHYDROGENASE ACTIVITY IN A CANINE MODELTransplantation, 1996
- Mycophenolic Acid: Measurement and Relationship to Pharmacologie EffectsTherapeutic Drug Monitoring, 1995
- Mechanisms of Action of Mycophenolic AcidAnnals of the New York Academy of Sciences, 1993
- Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytesBiochemical Journal, 1992